Vor Biopharma Inc.
VOR
$16.10
$1.177.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -883.08M | -695.98M | -2.45B | -1.66B | -118.60M |
| Total Depreciation and Amortization | 2.09M | 2.89M | 3.73M | 4.58M | 3.41M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 733.79M | 540.17M | 2.29B | 1.54B | 13.44M |
| Change in Net Operating Assets | -2.69M | 10.21M | 9.86M | 4.71M | 1.49M |
| Cash from Operations | -149.89M | -142.71M | -143.98M | -113.60M | -100.26M |
| Capital Expenditure | -758.00K | -941.00K | -699.00K | -489.00K | -346.00K |
| Sale of Property, Plant, and Equipment | 799.00K | 799.00K | 799.00K | 799.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -311.85M | -48.66M | 0.00 | 0.00 | 53.00M |
| Cash from Investing | -311.81M | -48.80M | 100.00K | 310.00K | 52.65M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 580.39M | 505.39M | 77.95M | 55.85M | 55.77M |
| Repurchase of Common Stock | -201.00K | -254.00K | -136.00K | -187.00K | -206.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -901.00K | -1.33M | 171.48M | 172.12M | -2.88M |
| Cash from Financing | 579.28M | 503.81M | 249.29M | 227.79M | 52.69M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 117.58M | 312.29M | 105.42M | 114.50M | 5.08M |